Major players in the amniotic membrane market are Alliqua BioMedical, Amnio Technology, Applied Biologics, Human Regenerative Technologies LLC, Rivela.
/PRNewswire/ The "Contact Lenses: Technologies and Global Markets" report has been added to ResearchAndMarkets.com s offering. The increasing prevalence of.
/PRNewswire/ The "Ophthalmic Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com s offering. In recent years there.
TissueTech Receives FDA Clearance to Proceed with Phase 1 Clinical Study using Investigational New Drug TTAX03 to Treat Facet Joint Osteoarthritis Pain
Investigators will evaluate the dosage and safety of Cryopreserved Amniotic Membrane and Cryopreserved Umbilical Cord TTAX03 for pain relief and functional improvement of facet joint osteoarthritis in the lumbosacral region
News provided by
Share this article
Share this article
MIAMI, March 8, 2021 /PRNewswire/ Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that its parent company TissueTech had received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a dosing study using its Investigational New Drug (IND) TTAX03 to treat facet joint pain resulting from Osteoarthritis (OA). This Phase 1 randomized, double-blinded, placebo-controlled, dose-finding study will include a one-year follow-up to assess TT